Electromedical Technologies, Inc EMED
OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2019-06-17
Electromedical Technologies, Inc financials (annual, from 10-K)
Bars are annual figures from 2019 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $1.3M | $1.1M | $907,362 | $737,958 | $829,737 |
| Gross profit | $1.0M | $888,641 | $708,128 | $543,574 | $591,221 |
| R&D expense | $231,434 | $92,299 | $215,320 | $31,600 | $82,849 |
| SG&A expense | $3.1M | $2.5M | $4.5M | $3.7M | $2.3M |
| Operating income | -$2.1M | -$1.6M | -$3.8M | -$3.2M | -$1.7M |
| Interest expense | $893,155 | $791,072 | $3.3M | $769,591 | $54,814 |
| Net income | -$2.6M | -$3.5M | -$8.5M | -$3.9M | -$1.7M |
| EPS (diluted) | $0.00 | $-0.03 | $-0.24 | $-0.20 | — |
| Operating cash flow | -$1.4M | -$773,337 | -$1.2M | -$1.3M | -$280,772 |
| Free cash flow | -$1.6M | — | — | — | — |
| Cash & equivalents | $87,704 | $368,425 | $383,170 | $264,913 | $0 |
| Inventory | $68,517 | $62,061 | $218,510 | $78,712 | $24,694 |
| Total assets | $748,383 | $1.4M | $1.4M | $1.4M | $902,866 |
| Total liabilities | $3.6M | $3.6M | $2.1M | $2.7M | $3.1M |
| Shareholders' equity | -$2.9M | -$2.2M | -$722,503 | -$1.3M | -$2.2M |
Growth · year-over-year · Revenue CAGR 12.9%
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue growth | +17.3% | +26.7% | +23.0% | -11.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001715819 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.